The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies. Since its founding in 1974, the association’s membership has grown to more than 8,000 lung and thoracic cancer specialists from all disciplines and more than 100 countries.
By hosting global conferences, funding cutting-edge research, and educating the health care community and the public about thoracic cancers, the IASLC works to alleviate the burden lung cancer places on patients, families, and communities.
The IASLC's Mission
Be the multidisciplinary world authority on lung and other thoracic cancers through collaborative science, education, and advocacy in order to ensure optimal prevention and patient care.
The IASLC's Vision
Conquering Lung and Other Thoracic Cancers Worldwide in the 21st Century.
Board of Directors
The IASLC’s multidisciplinary board brings a wealth of clinical and scientific thoracic oncology expertise, a close familiarity with institutional leadership and tremendous passion for ongoing improvements to care of patients with lung cancer.
The staff of the IASLC is united in a shared passion to conquer lung cancer by serving its members worldwide.